Bolton Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.8M Buy
17,949
+1,202
+7% +$1.42M 0.78% 20
2026
Q2
$20.1M Buy
16,747
+5,023
+43% +$5.13M 0.75% 21
2026
Q1
$10.8M Sell
11,724
-47
-0.4% -$47.6K 0.51% 37
2025
Q4
$12.7M Buy
11,771
+1,569
+15% +$1.5M 0.59% 31
2025
Q3
$7.78M Buy
10,202
+371
+4% +$276K 0.37% 53
2025
Q2
$7.66M Buy
9,831
+1,084
+12% +$842K 0.4% 51
2025
Q1
$7.22M Buy
+8,747
New +$7.28M 0.43% 50

Other funds holding LLY

Bolton Securities's LLY Position: Q3 2026 in Review

Bolton Securities increased its Eli Lilly (LLY) stake by 7.2% in Q3 2026, buying an estimated $1.42M and bringing the position to 17,949 shares worth $20.8M. The position accounts for 0.78% of the portfolio, ranked #20.

Bolton Securities first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Bolton Securities held 17,949 shares of Eli Lilly worth $20.8M as of Q3 2026.
  • Bolton Securities bought 1,202 Eli Lilly shares in Q3 2026, an estimated $1.42M.
  • Eli Lilly made up 0.78% of Bolton Securities's portfolio in Q3 2026, its #20 holding.
  • Bolton Securities first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.